Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

TECENTRIQ

ATEZOLIZUMAB

Standard Dose
1200MG/20ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary

Approval overview TECENTRIQ is listed in Drugs@FDA under application 761041 (BLA).

Review priority: PRIORITY Marketing status: Prescription Active ingredient ATEZOLIZUMAB Form and strength INJECTABLE; INJECTION - 1200MG/20ML Sponsor GENENTECH INC Submission history Latest submission status date: 2016-10-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview TECENTRIQ is listed in Drugs@FDA under application 761041 (BLA). Review priority: PRIORITY Marketing status: Prescription Active ingredient ATEZOLIZUMAB Form and strength INJECTABLE; INJECTION - 1200MG/20ML Sponsor GENENTECH INC Submission history Latest submission status date: 2016-10-18 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.